Endocannabinoid System and Prenatal Cannabis: Clinical Research
Prenatal cannabis neurodevelopment risks include modestly increased chances of autism spectrum disorder and ADHD in offspring. Cannabis crosses the placenta and interacts with the endocannabinoid system during fetal brain development. Clinical research…
Exploring the Internalising Pathway of Cannabis Use in Teens
The internalising pathway cannabis use teens highlights how anxiety symptoms increase the risk of cannabis initiation and escalation. Adolescents with generalised anxiety are particularly vulnerable. Early intervention targeting these symptoms may reduce…
Adolescent Cannabis Use and New Psychiatric Diagnoses Risk
Adolescent cannabis use new psychiatric diagnoses risk is a critical concern for mental health professionals. Evidence shows that cannabis use during adolescence increases the likelihood of developing psychiatric disorders. Early screening and…
Endocannabinoid System in First-Episode Psychosis Care
People with first-episode psychosis have elevated rates of criminal legal involvement that are measurable at baseline and predictable using identifiable clinical and demographic factors. Early identification of individuals at higher risk for legal…
Endocannabinoid System in Trauma: Clinical Research Evidence
Clinical research highlights the role of the endocannabinoid system trauma substance use connection in posttraumatic outcomes. Insomnia symptoms before trauma predict higher rates of alcohol and cannabis use. Understanding this link aids early…
Cannabidiol Cortical Excitability Clinical Trial
This cannabidiol cortical excitability clinical trial data shows CBD did not directly reduce brain electrical excitability at doses up to 700 mg in healthy adults. The findings suggest seizure-control benefits likely arise from interactions with other…
Insights from Cannabinoid Sleep Trials: EEG Insomnia Research 2026
Cannabinoid sleep trials EEG insomnia research 2026 reveal that a single dose of THC/CBD affects sleep architecture in insomnia patients. This pilot study shows reduced total sleep time and REM sleep suppression. Further research is needed to assess…
Daily Cannabis Use and Anxiety Relief: Outcomes by Product Type
Daily cannabis anxiety relief outcomes vary significantly by product type and cannabinoid composition. Research shows that flower and edible cannabis products produce different anxiety symptom changes over time. Understanding these outcomes helps guide…
Clinical Research on Endocannabinoid System and PTSD Treatment
Endocannabinoid system PTSD cannabis research reveals trauma-focused treatments remain effective for patients using cannabis. Clinical data shows no significant impairment in therapy outcomes due to cannabis use. These findings support standard…
Understanding the Endocannabinoid System in Clinical Cannabis Care
The endocannabinoid system clinical relevance is crucial in understanding cannabis care. This system plays a key role in mental health and substance use outcomes. Digital interventions targeting this system offer promising clinical benefits.
